Search

• Decade: 2010s ×
• Written by: M. Altomonte ×
• Clear filters

1 result for “Union Carbide Corporation”

1. Medical study · Medical research · 2015

   Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study

   …response (complete or partial), assessed in all patients who received at least one dose of the study drug. This study is registered with the European Union Clinical Trials Register, number 2012-002762-12, and ClinicalTrials.gov…